Blood Culture Diagnostics Market Outlook 2024-2031: Advancements in Molecular Testing, Laboratory Automation & Infection Control Initiatives

Blood Culture Tests Market Size and Forecast

Blood Culture Tests Market was valued at USD 4357.91 million in 2022 and is estimated to reach USD 8600.93 million by 2031, growing at a CAGR of 9.1% during the forecast period 2024-2031.

DataM Intelligence has published a new research report on "Blood Culture Tests Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/blood-culture-tests-market?rk

Recent Developments:
✅ October 2025: bioMérieux introduced an upgraded automated blood culture system with enhanced microbial detection algorithms and reduced time-to-detection capabilities. The platform integrates advanced data analytics to support rapid identification of bloodstream infections (BSIs), improving clinical decision-making in critical care and emergency settings.

✅ September 2025: Becton, Dickinson and Company expanded its blood culture media portfolio with next-generation resin-based bottles designed to neutralize a broader range of antibiotics. This innovation improves pathogen recovery rates, particularly in patients already receiving antimicrobial therapy.

✅ August 2025: Thermo Fisher Scientific launched a compact, laboratory-friendly blood culture incubation system targeting mid-sized hospitals and diagnostic laboratories. The system emphasizes workflow automation, contamination reduction, and compatibility with molecular diagnostic platforms.

✅ June 2025: Danaher Corporation, through its diagnostics subsidiaries, introduced AI-enabled blood culture monitoring software capable of early sepsis risk prediction. The solution supports antimicrobial stewardship programs and aligns with global efforts to reduce hospital-acquired infections (HAIs).

Mergers & Acquisitions:
✅ November 2025: A leading global diagnostics manufacturer acquired a rapid molecular microbiology startup to strengthen its blood culture identification portfolio and accelerate time-to-result capabilities for sepsis management.

✅ September 2025: A major in-vitro diagnostics (IVD) company completed the acquisition of a blood culture consumables producer to expand its manufacturing capacity and improve supply chain resilience amid rising global demand.

✅ July 2025: A multinational healthcare technology group acquired a digital microbiology software firm specializing in laboratory automation and culture data analytics, enhancing integration between blood culture systems and hospital information systems.

✅ May 2025: A prominent medical device company acquired a clinical microbiology reagent manufacturer to broaden its offerings in blood culture media and antimicrobial susceptibility testing, supporting comprehensive infectious disease diagnostics solutions.

Key Players:

Thermo Fisher Scientific Inc., Becton Dickinson and Company, Abbott Laboratories, bioMerieux S.A., Danaher Corporation, F. Hoffman-La Roche, Luminex Corporation, Bruker Corporation, OpGen Inc., T2 Biosystems Inc.

Growth Forecast Projected:

The Global Blood Culture Tests Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Blood Culture Tests Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=blood-culture-tests-market?rk

Key Segments:

By Product
The market is segmented into Consumables 45%, Instruments & Equipment 30%, Software & Services 15%, and Accessories 10%, with consumables dominating due to recurring demand for blood culture media, assay kits, reagents, and testing supplies. Automated blood culture systems and incubators form a major part of the instruments segment, driven by increasing laboratory automation. Software and services are gaining traction as laboratories adopt digital workflow management and data integration systems for faster diagnosis and reporting.

By Technology
By technology, the market includes Culture-Based 50%, Molecular-Based 25%, Proteomic-Based 15%, Polymerase Chain Reaction (PCR) 7%, and Microarray 3%, with culture-based methods leading due to their gold-standard status in detecting bloodstream infections. Molecular-based and PCR technologies are growing rapidly due to faster turnaround times and improved sensitivity. Proteomic-based techniques are increasingly used for pathogen identification, particularly in advanced hospital laboratories.

By Application
The market is segmented into Bacterial Infection 65%, Fungal Infection 20%, Mycobacterial Infection 10%, and Others 5%, with bacterial infections dominating due to high prevalence of sepsis and bloodstream infections globally. Fungal infections contribute significantly, particularly in immunocompromised patients. Mycobacterial infections, including tuberculosis-related bloodstream infections, represent a smaller but important segment.

By End-User
The market comprises Hospital Laboratories 70%, Private Laboratories 25%, and Others 5%, with hospital laboratories leading due to high patient inflow, emergency care requirements, and integrated diagnostic capabilities. Private laboratories are expanding steadily, supported by outsourcing trends and growing demand for specialized diagnostic services.

Regional Analysis
North America - 38% Share
North America leads with 38% share driven by advanced healthcare infrastructure, high sepsis awareness, and strong adoption of automated blood culture systems. The U.S. dominates the region with robust reimbursement systems and infection control initiatives.

Europe - 27% Share
Europe accounts for 27% share, supported by increasing antimicrobial resistance (AMR) surveillance programs and rising hospital-acquired infection monitoring across Germany, France, and the UK.

Asia Pacific - 22% Share
Asia-Pacific holds 22% share driven by large patient populations, increasing infectious disease burden, and expanding healthcare infrastructure in China, India, and Japan.

Latin America - 8% Share
Latin America captures 8% share, supported by improving laboratory capacity and infection management programs in Brazil and Mexico.

Middle East & Africa - 5% Share
The Middle East & Africa region holds 5% share, driven by gradual improvement in diagnostic infrastructure and increasing focus on sepsis management in GCC countries and South Africa.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/blood-culture-tests-market?rk

FAQ

Q1: What is the current size of the Blood Culture Tests Market?

A: The Blood Culture Tests Market was valued at USD 4357.91 million in 2022 and is estimated to reach USD 8600.93 million by 2031.

Q2: How rapidly will the Market expand?

A: The Blood Culture Tests market is projected to grow at a CAGR of 9.1% between 2025 and 2032.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.